Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: Is it alone sufficient to predict adenoviral disease?
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Saliha Kanık Yüksek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Disease, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Adenoviridae Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
We aimed to evaluate our pediatric HSCT recipients routinely monitored for adenoviremia and to determine the adequacy of this monitoring in predicting adenoviral disease (AD).
Methods
A retrospective cohort of patients who underwent allogeneic HSCT between January 2021 and August 2022, and routinely monitored for adenoviremia by real‐time PCR was included in our survey. Demographic and clinical data of the patients were recorded. Incidence rates, risk factors, and mortality rates related to adenoviremia, and AD were analyzed.
Results
Among 104 HSCTs performed in 94 patients adenovirus (AdV) was revealed in 27 (26%) episodes and adenoviremia in 18 (17.3%) HSCT episodes. AD without adenoviremia developed in nine episodes (8.6%). Disseminated disease was significantly more frequently detected in episodes with adenoviremia ( p = .008). GVHD was independent risk factor for AdV detection (OR: 8.6, 95% CI: 2.03–33.7, p = .001). Viremia developed within a shorter time interval after HSCT in isolated episodes of adenoviremia compared to those with concomitant AD ( p = .006). Initial and peak viral loads were significantly higher in adenoviremia with AD ( p < .001). Mortality was higher in the AdV‐detected episodes ( p < .001) than in the AdV‐undetected episodes. AdV‐related mortality was found to be 22.2%. Adenoviremia increased the risk of mortality (OR: 1.2, 95% CI: 0.22–1.33, p = .01).
Conclusions
Adenoviremia monitoring is an important process in the detection of AD. Since some patients may develop AD without accompanying by adenoviremia, monitoring for AdV in blood samples should be supported with other monitoring methods in order to evaluate the probable involvement of different organs or systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Infectious Disease, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Hematology/Oncology, Paediatric Bone Marrow Transplantation Unit, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Infectious Disease, Ankara Yıldırım Beyazıt University, Ankara Bilkent City Hospital, Ankara, Turkey.
ORCID-Profile: Saliha Kanık Yüksek, Özlem Arman Bilir
Zitieren
APA
Kanık Yüksek, S., Arman Bilir, Ö., Erat, T., Gülhan, B., Kanbur, Ş. M., Bayhan, G. İ., Ok Bozkaya, İ., Özkaya Parlakay, A., & Özbek, N. Y. (2024). Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: Is it alone sufficient to predict adenoviral disease?. Pediatric Transplantation. https://doi.org/10.1111/petr.14696
Vancouver
Kanık Yüksek S, Arman Bilir Ö, Erat T, Gülhan B, Kanbur ŞM, Bayhan Gİ, et al. Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: Is it alone sufficient to predict adenoviral disease?. Pediatric Transplantation. 2024. doi:10.1111/petr.14696
BibTeX
@article{KankYksek2024,
author = {Kanık Yüksek, Saliha and Arman Bilir, Özlem and Erat, Tuğba and Gülhan, Belgin and Kanbur, Şerife Mehtap and Bayhan, Gülsüm İclal and Ok Bozkaya, İkbal and Özkaya Parlakay, Aslınur and Özbek, Namık Yaşar},
title = {Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: Is it alone sufficient to predict adenoviral disease?},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14696}
}
EUVIMED